The Agonist-to-Antagonist Action of Psychopharmacologic Agents
The Agonist-to-Antagonist Action of Psychopharmacologic Agents The use of pharmacological treatments for opioid use disorders, including methadone, buprenorphine, and naltrexone, has been associated with a reduction in mortality compared with illicit opioid use. The opioid agonist methadone and buprenorphine achieve clinical efficacy in patients with an opioid use disorder by suppressing craving and diminishing […]